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We examined the genetic context of 74 acquired ampC genes and 17 carbapenemase genes from 85 of 640 Enterobacteriaceae iso-
lates collected in 2009. Using S1 pulsed-field gel electrophoresis and Southern hybridization, 37 of 74 blaAmpC genes were located
on large plasmids of different sizes belonging to six incompatibility groups. We used sequencing and PCR mapping to investi-
gate the regions flanking the acquired ampC genes. The blaCMY-2-like genes were associated with ISEcp1; the surrounding blaDHA
genes were similar to Klebsiella pneumoniae plasmid pTN60013 associated with IS26 and the psp and sap operons; and the
blaACC-1 genes were associated with IS26 elements inserted into ISEcp1. All of the carbapenemase genes (blaVIM-1, blaIMP-22, and
blaIMP-28) were located in class 1 integrons. Therefore, although plasmids are the main cause of the rapid dissemination of ampC
genes among Enterobacteriaceae, we need to be aware that other mobile genetic elements, such as insertion sequences, trans-
posons, or integrons, can be involved in the mobilization of these genes of chromosomal origin. Additionally, three new inte-
grons (In846 to In848) are described in this study.
Beta-lactam resistance in Enterobacteriaceae due to acquiredAmpC -lactamases (pAmpC) or carbapenemases represents
an emerging and increasing problem that limits therapeutic
options. pAmpC confer resistance to most -lactams, except
cefepime and carbapenems, whereas carbapenemases, including
classes A, B, and D, can confer resistance to most -lactams, in-
cluding carbapenems. The number of Enterobacteriaceae isolates
carrying these enzymes is lower than that of extended-spectrum
-lactamase-producing isolates, but the number has increased
over the last few years, particularly for pAmpC CMY-2 and DHA
and for carbapenemase types NDM, VIM, IMP, and OXA-48
(1, 2).
Both families of enzymes (pAmpC and carbapenemases) are
normally codified in plasmids, and their genes are associated with
mobile genetic elements (MGE), such as insertion sequences,
transposon-like elements, and class 1 integrons. All of these MGE
can transfer these genes into mobilizable and conjugative plas-
mids and subsequently disseminate them into many bacterial spe-
cies that naturally lack these genes (3–5).
As previously described (3), 100,132 Enterobacteriaceae isolates
were collected from February to July 2009 from 35 Spanish hos-
pitals. Among them, we found a total of 674 Enterobacteriaceae
isolates with acquired ampC and/or carbapenemase genes. The
following enzyme types were found: CMY-2-like (74.3%), DHA
(17.8%), ACC (1.5%), FOX (0.6%), VIM (4.3%), and IMP (1.5%)
(3). Although a great genetic diversity among pAmpC-producing
strains was observed, some clonal relationships were established
between these isolates, mainly in carbapenemase-producing
strains (3).
This study aimed to describe the plasmid families and the
surrounding regions involved in the dissemination of a great
diversity of acquired ampC and metallo--lactamases genes in
Enterobacteriaceae isolates lacking inducible chromosomal AmpC
enzymes.
MATERIALS AND METHODS
Clinical isolates. To characterize the plasmids and flanking regions im-
plicated in the expansion of these genes, we selected 85 strains from the
collection cited above (3). The selection was made on the basis of preva-
lence, and strains that produced new enzymes were also included.
PCR-based replicon typing. PCR-based incompatibility (Inc)/repli-
con typing (PBRT) was used to identify the major Inc groups of the plas-
mids present (4, 6).
Plasmid profiles and Southern blot analysis. Plasmid analysis was
carried out by DNA linearization with the S1 enzyme followed by pulsed-
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field gel electrophoresis (PFGE), as previously described (7). Plasmid sizes
were estimated using Fingerprinting II Informatix software (Bio-Rad) (7).
A PCR Dig probe synthesis kit (Roche Diagnostics GmbH, Mannheim,
Germany) was used to obtain blaAmpC or Inc probes for hybridization of
the S1-PFGE blots. These probes were labeled with the commercial kit
(Dig high-prime DNA labeling and detection starter kit II; Roche Diag-
nostics GmbH).
The chromosomal location of bla genes was analyzed by digesting the
TABLE 1 Flanking regions and plasmid families associated with acquired AmpC and carbapenemases in Enterobacteriaceae
bla gene(s) Flanking region(s)a
Plasmid size(s) or
localization (kb)b Replicon Microorganism(s) (no. of isolates)
blaACC-1 ACC-1(B) 64.5 N K. pneumoniae (1); E. coli (1)
ACC-1(B) Chromosomal E. coli (1); Proteus mirabilis (1)
ACC-1(B) 80 Unidentified K. pneumoniae (1)
ACC-1(C) 32.5 Unidentified P. mirabilis (1)
ACC-1(D) 48.5 Unidentified K. pneumoniae (1)
blaACC-1  blaFOX-3 ACC-1(A)  FOX (A) 64.5  80.5 Unidentified  U E. coli (1)
blaCMY-2 CMY-2(A) 177.5 to 300.7 A/C K. pneumoniae (2); P. mirabilis (1)
CMY-2(A) 43.7 to 83.1 I1 Citrobacter koseri (1); E. coli (4)
CMY-2(A) 69.3 I1  FIB E. coli (1)
CMY-2(A) 48.5 to 83.1 K E. coli (3); K. pneumoniae (1)
CMY-2(A) Chromosomal E. coli (1); Klebsiella oxytoca (1)
CMY-2(B) 55.4 K E. coli (1)
CMY-2(B) 76.2 I1 E. coli (1)
CMY-2(C) 145.5 I1 K. pneumoniae (1)
CMY-2(C) Chromosomal P. mirabilis (3); K. pneumoniae (1);
Proteus penneri (1)
CMY-2(D) 83.1 to 97.6 I1 E. coli (1); K. pneumoniae (1)
blaCMY-4 CMY-2(A) 105.1 K  FIB E. coli (1)
CMY-2(A) Chromosomal E. coli (1)
CMY-2(B) 80.8 I1 E. coli (1)
CMY-2(C) 88.9 I1 K. pneumoniae (1)
blaCMY-7 CMY-2(A) 80.8 I1 E. coli (1)
blaCMY-27 CMY-2(A) 113.2 I1 E. coli (2)
blaCMY-43 CMY-2(A) Chromosomal E. coli (1)
blaCMY-48 CMY-2(B) Chromosomal E. coli (1)
blaCMY-54 CMY-2(C) 105.1 K  FIB E. coli (1)
blaCMY-55 CMY-2(A) 282.9 A/C E. coli (1)
blaCMY-56 CMY-2(A) 299.1 A/C K. pneumoniae (1)
blaCMY-57 CMY-2(C) 97.0 I1 E. coli (1)
blaCMY-2  blaDHA-1 CMY-2(A)  DHA-1(G) Chromosomal  218 FIIA K. pneumoniae (1)
blaCMY-2  blaVIM-1 CMY-2(C)  VIM-1(B) Chromosomal  48 Unidentified P. mirabilis (1)
blaDHA-1 DHA-1(A) 72.8 to 87.3 Unidentified C. koseri (1); E. coli (1); K.
pneumoniae (2)
DHA-1(A) 203.7 A/C K. pneumoniae (1)
DHA-1(A) Chromosomal C. koseri (1); Enterobacter cloacae (1)
DHA-1(B) 72.8 Unidentified K. oxytoca (2)
DHA-1(B) 77.6 I1 E. coli (1)
DHA-1(C) Chromosomal P. mirabilis (3)
DHA-1(D) 72.8 Unidentified K. oxytoca (1)
DHA-1(E) 72.8 Unidentified Salmonella spp. (1)
DHA-1(F) 87.3 Unidentified E. coli (1)
DHA-1(H) Chromosomal E. coli (1)
blaDHA-6 DHA-1(G) 87.3 I1 E. coli (1)
blaDHA-1  blaVIM-1 DHA-1(B)  VIM-1 (D) (In846) 76.6  chromosomal FIIA K. pneumoniae (1)
blaDHA-7  blaVIM-1 DHA-1(D)  VIM-1(E) (In847) 310.4  48.5 HI2  unidentified E. cloacae (2)
blaFOX-3 FOX(A) 72.5 U E. coli (1)
blaFOX-8 FOX(A) Chromosomal E. coli (2)
blaIMP-22 IMP-22(A) 485.0 Unidentified K. pneumoniae (2)
blaIMP-28 IMP-28(A) (In767) Chromosomal K. oxytoca (1)
blaVIM-1 VIM-1(A) (In488) 48.0 Unidentified K. oxytoca (1)
VIM-1(B) (In624) 48.0 and 66.2 Unidentified E. cloacae (2); K. oxytoca (2); K.
pneumoniae (2)
VIM-1(C) (In846) 48.0 and 72.5 U K. pneumoniae (1); E. cloacae (1)
VIM-1(D) (In848) 48.0 Unidentified E. coli (1)
a The type of surrounding regions found for each bla gene is in parentheses (see Fig. 1 to 3 for more data).
b The plasmid size was determined after the hybridization procedure. Chromosomal means possible chromosomal localization of the gene.
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genomic DNA with the ICeuI enzyme, followed by PFGE and hybridiza-
tion blotting as described above.
Genetic environment characterization of acquired ampC and car-
bapenemase genes. The genetic context was investigated by exploring the
regions surrounding acquired blaAmpC and carbapenemase genes fre-
quently reported in the literature (8–14), employing PCR and sequencing
with previously described primers. Additionally, primers designed in ac-
cordance with accessible DNA sequences in GenBank (accession numbers
AY581207, AJ870924, Y11068, AJ971345, and EF577408) were used to
ascertain the presence of genes linked to the acquired blaAmpC and car-
bapenemase genes (see Table S1 in the supplemental material). Sequenc-
ing reactions were performed with the BigDye terminator kit (PE Applied
Biosystems, Foster City, CA), and sequences were analyzed on an ABI
Prism 3100 DNA sequencer (PE Applied Biosystems). The resulting se-
quences were then compared with those available in the GenBank data-
base (www.ncbi.nih.gov/BLAST).
Nucleotide sequence accession numbers. Sequences with new inte-
grons were submitted to GenBank under the accession numbers
KC417378 (In846), KC417379 (In847), and KC417377 (In848).
RESULTS
Among the 85 selected strains (66 pAmpC-producing strains, 13
IMP/VIM-producing strains, 4 strains that produced both en-
zymes, and 2 strains that produced two pAmpC), we characterized
the plasmids and flanking regions of 91 genes: 74 blaAmpC genes, 3
blaIMP genes, and 14 blaVIM genes (Table 1).
The studied blaAmpC genes included blaCMY-2-like (40), blaDHA
(22), blaACC (8), and blaFOX (4), while the metallo--lactamase
genes included blaVIM-1 (14), blaIMP-22 (2), and blaIMP-28 (1).
Plasmid characterization. Analysis by S1-PFGE and Southern
hybridization allowed us to determine the plasmid size for 74.7%
FIG 1 The genetic environment of blaCMY-2-like and blaACC genes, which are indicated by solid black arrows; the surrounding genes are indicated by white
arrows. The dashed lines indicate the areas that could not be amplified by PCR. Eight isolates contained truncated versions of ISEcp1 at the 3= end (A.1)
and the 5= end (A.2). Truncated genes are indicated by disrupted arrows. One isolate (C) carrying the blaACC gene showed a structure identical to that of
GenBank accession no. AJ870924. In one isolate (D), IS26 was truncated by a tnpR gene of insertion Tn5393. The primers used for PCR amplification are
also shown.
Zamorano et al.
5262 aac.asm.org September 2015 Volume 59 Number 9Antimicrobial Agents and Chemotherapy


























(68 of 91) of the studied genes, leaving 23 genes (25.3%) with a
possible chromosomal location (positive hybridization in ICeuI-
PFGE). Nevertheless, we were able to describe the incompatibility
group by PCR-based replicon typing (PBRT) among these 68 plas-
midic genes in only 41 cases (60.3%).
We found that 39 of 74 blaAmpC genes (50%) were located in
large plasmids of different sizes belonging to eight Inc groups,
including A/C, FIB, FIIA, I1, K, HI2, N, and U. The most repre-
sentative, present alone or together with other replicons, were I1
(n  18; one also with FIB), K (n  7; two also with FIB), A/C
(n  6), FIIA (n  2), HI2 (n  2), and N (n  2) (Table 1). In 13
of 74 blaAmpC genes (17.5%), the plasmid replicon was not iden-
tified. (In 10 cases, PBRT was positive for different replicons, but
their hybridization bands did not match the blaAmpC band, and
PBRT was negative in 3 cases.) Finally, in 22 cases (29.7%), a
possible chromosomal location of these genes was confirmed by
ICeuI-PFGE.
The plasmids carrying blaCMY-2-like genes belonged to the fol-
lowing Inc groups: I1 (16 of 40 [37.5%]; sizes ranged from 43.7 to
145.5 kb), K (7 of 40 [17.5%]; sizes ranged from 48.5 to 105.1 kb),
and A/C (5 of 40 [12.5%]; sizes ranged from 177.5 to 300.7 kb). In
three cases, the FIB plasmid was also found to be associated with
one IncI1 or two IncK plasmids (Table 1).
Seven of 22 plasmids carrying blaDHA genes were characterized,
and the following Inc groups were found: I1 (9%; 77.6 and 87.3
kb), FIIA (9%; 76.6 and 218 kb), HI2 (9%; 291 kb), and A/C
(4.5%; 203.7 kb). The remaining 15 cases were not resolved be-
cause no incompatibility group probes were hybridized (n  11)
or because of a negative PBRT (n  4).
Only 2 of the 8 plasmids carrying blaACC-1 were identified, and
they belonged to the IncN group, with sizes ranging from 32.5 to
80 kb. The blaFOX-3 genes were found in plasmids of 72.5 and 80.5
kb, both in the IncU group, and the blaFOX-8 gene (15) was prob-
ably located on the chromosome.
Finally, the sizes of the 14 plasmids carrying the blaVIM-1 gene
ranged from 48 to 72.5 kb, and one of them belonged to the IncU
group; the blaIMP-22 genes were in plasmids of 485 kb with an
unidentified Inc group. The blaIMP-28 gene was probably located
on the chromosome, as previously described (16).
Detection of the flanking regions of acquired ampC and me-
tallo--lactamase genes. The variable genetic environments de-
tected for the most prevalent enzymes (CMY-2-like, DHA, ACC,
and metallo--lactamase genes) are shown in Fig. 1, 2, and 3.
The analysis of the genetic environment revealed that blaCMY-2-
like genes (blaCMY-2, blaCMY-4, blaCMY-7, blaCMY-27, blaCMY-48,
blaCMY-54 and/or blaCMY-57, blaCMY-59, and blaCMY-60) were asso-
ciated with ISEcp1, responsible for the transfer of the blaCMY-2-
like–blc–sugE region from the chromosome of Citrobacter freundii
to plasmids (8). In our study, 16 strains contained ISEcp1 and
blc-sugE-ecnR upstream and downstream of blaCMY-2-like genes,
FIG 2 The genetic environment of the blaDHA gene, which is indicated by solid black arrows; the surrounding genes are indicated by white arrows. Lines indicate
an absence of the corresponding DNA fragments.
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respectively. However, truncation of ISEcp1(ISEcp1) was ob-
served in 8 strains: in 4 at the 3=end and in 4 at the 5=end. In the 4
strains with truncation at the 3= end, primers described to explore
this region (ISEcp1 and CMY2Ri) (see Table S1 in the supplemen-
tal material) amplified a product of 1,560 bp instead of the ex-
pected 2,160 bp. In the 4 strains with truncation at the 5= end, the
amplicons were not obtained using ISEcp1 and CMY2Ri primers,
and we required a new pair of primers (TnpA1L and CMY2Ri).
Finally, 12 strains did not contain ISEcp1 upstream, and the region
downstream of the blaCMY-2-like gene could not be amplified by
PCR in 6 strains with the primers used. Only in 2 strains with
complete blaCMY-2-like genes was the genetic environment un-
known (Fig. 1).
The surrounding regions of blaDHA genes (blaDHA-1, blaDHA-6,
and blaDHA-7) were similar to those previously described in Kleb-
siella pneumoniae plasmid pTN60013 (GenBank accession num-
ber AJ971345) (5), although a certain variability was detected in
accordance with the literature data (11, 17). This variability
mainly concerned the absence or presence of sapB, sapA, and sdr
genes (Fig. 2). The quinolone resistance determinant qnrB4 and
additional aadA1 (streptomycin and spectinomycin resistance)
genes were detected in most of the strains. This linkage between
blaDHA-1 and qnrB4 genes has been previously described in isolates
of K. pneumoniae (11).
In the environment of the blaACC gene, ISEcp1 and the gdhA
gene were detected upstream and downstream, respectively. In all
cases, ISEcp1 was truncated in the 5= end (13). Six of eight blaACC
genes showed two IS26 copies in the same orientation; one of these
strains contained a truncated 5= gdhA, and one contained a tnpR
gene of Tn5393 upstream of the gdhA gene.
Four blaFOX genes, blaFOX-3 (n  2) and blaFOX-8 (n  2), were
located in a class I integron, at the 5= end of the integrase INI1, and
several attempts to identify the 3= end by PCR were unsuccessful.
All the metallo--lactamase genes (14 blaVIM-1, 2 blaIMP-22, and 1
blaIMP-28) were located in class 1 integrons (In). In this study, we
detected 5 different structures harboring blaVIM genes (Fig. 3); In846
(GenBank accession number KC417378), In847 (KC417379), and
In848 (KC417377) were described for the first time.
FIG 3 Structure of blaVIM-1, blaIMP-22, and blaIMP-28 genes carrying the integrons described in this work. Carbapenemase genes are indicated by solid black
arrows, and the surrounding genes are indicated by white arrows. The locations of the primers used for PCR amplification are also shown.
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We have characterized the genetic context of the largest avail-
able collection of acquired AmpC -lactamases and metallo--
lactamases in Enterobacteriaceae lacking inducible chromosomal
AmpC enzymes recovered during 2009 from 35 Spanish hospi-
tals (3).
Several authors have related the spread of different acquired
AmpC genes with the expansion of plasmids of certain incompat-
ibility groups (1, 2, 4, 5, 7, 18–21). In this context, the blaCMY-2
gene is associated with plasmids of I1, A/C, and K incompatibility
groups (7, 18–21). Our results match these data, but differences
were found in the percentage of each incompatibility group. In a
previous study (7) carried out during 1999 to 2007, A/C was the
most predominant incompatibility group found (33%) among
plasmids carrying blaCMY-2, followed by I1 (23%) and K (10%). In
this study (with strains isolated in 2009), the most prevalent in-
compatibility group was I1 (40%), followed by K (17.5%) and A/C
(12.5%). The fact that different Inc plasmids have been found to
carry the same resistance gene is an indication of a successful and
widespread distribution; moreover, this variability contributes to
the genetic environment of these genes (20). The IncA/C and
IncI1 are considered epidemic plasmids, because they are found in
different countries and in bacteria of diverse origin, and because
they carry a range of resistance mechanisms (4). IncA/C plasmids
have been described carrying ESBLs that are TEM-type or VEB, as
well as NDM-1 carbapenemase. On the other hand, IncI1 has an
efficient conjugative system that could also contribute to the dis-
semination of different resistance mechanisms, such as ESBLs that
are CTX-M-type and TEM-type (4).
The genetic environment of blaCMY-2 and its variants was
highly conserved; 60% of isolates carried the transposon-like ele-
ments ISEcp1 (ISEcp1/ISEcp1-blaCMY-blc-sugE), as documented
in previous reports (8, 10, 18). As these blaCMY-2-derived blaCMY
genes differ from one other by only a few nucleotide substitutions,
it is possible that these differences could have evolved within the
same Inc plasmid (I1) (20). The genes blaCMY-55 and blaCMY-56
were found in the A/C plasmid, and the blaCMY-54 gene was found
in a K plasmid, in this case cointegrated with FIB.
The blaDHA-1 genes were initially associated with IncFII plas-
mids (20), but recent studies link them with IncL/M plasmids and
qnrB determinants (5, 7). Among our DHA-producing strains, 19
showed the qnrB4 determinant (data not shown), and none was
associated with the IncL/M plasmids. In fact, we were able to char-
acterize the plasmid in only 7 cases (38.8%); I2, FIIA, and HI2
were the incompatibility groups found. The genetic organization
of blaDHA genes was more variable. Mobilization of this enzyme
has been associated with IS26 or class 1 integron-bearing ISCR1
elements (11, 18). Among blaDHA-carrying isolates, 86% were as-
sociated with IS26.
In the literature, characterization of plasmids carrying blaACC-1
genes is scarce. In a previous study, a blaACC-1 gene in an Esche-
richia coli strain was found in an IncI1 plasmid (7), but other
authors could not type it (21). Regarding the genetic context of
blaACC-1 genes, an ISEcp1element truncated at the 5= end with an
IS26 insertion sequence was found in all of our blaACC-1-carrying
isolates, as described in previous reports (12, 13).
blaFOX and all carbapenemases detected in this study, including
previously undescribed structures (in blaFOX), were located in a
class 1 integron and present in the most recent IncU plasmids.
There are few data on the types of plasmids involved in
the spread of metallo--lactamases. In the literature, blaIMP and
blaVIM genes are described in plasmids of incompatibility groups
I1, N, W, and HI2 (4). In this study, the blaIMP-22 gene was located
in a 485-kb plasmid of an uncharacterized incompatibility group,
and two blaVIM-1 genes were found in IncU plasmids, curiously
both isolated from different species but in the same hospital. Fi-
nally, the location of the blaIMP-28 gene seems to be chromosomal,
as blaIMP-28-positive hybridization was found in the ICeuI-PFGE
membrane.
Accordingly, the high number of unidentified replicons could
be associated with plasmids other than those tested; alternatively,
they could be associated with one of the tested plasmids, albeit
with some genetic variability, as has been described for the car-
bapenemase NDM in plasmids with a variant of the IncN or In-
cHI1 groups (4).
In conclusion, although plasmids have proven to be one of
the main causes of the rapid dissemination of blaAmpC and
carbapenemase genes among bacteria, other MGE must play an
important role in the increasing prevalence of these enzymes. Fur-
ther studies, focused not only on plasmids but also on other MGE,
such as insertion sequences, transposons, or integrative conjuga-
tive elements, are needed to gain a better understanding of the
complex process involved in the dissemination of antibiotic resis-
tance genes worldwide.
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